Brooks Morgan M, Neelam Sudha, Cammarata Patrick R
Department of Cell Biology and Anatomy, University of North Texas Health Science Center at Fort Worth, Fort Worth, TX.
Mol Vis. 2013 Nov 29;19:2451-67. eCollection 2013.
Loss of integrity of either the inner or outer mitochondrial membrane results in the dissipation of the mitochondrial electrochemical gradient that leads to mitochondrial membrane permeability transition (mMPT). This study emphasizes the role of glycogen synthase kinase 3beta (GSK-3β) in maintaining mitochondrial membrane potential, thus preventing mitochondrial depolarization (hereafter termed mitoprotection). Using 3-(2,4-dichlorophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione (SB216763), an inhibitor of GSK-3β, and drawing a distinction between it and 1,4-diamino-2,3-dicyano-1,4-bis[2-aminophenylthio] butadiene (UO126), an inhibitor of extracellular-signal-regulated kinase (ERK) phosphorylation, the means by which GSK-3β influences mitoprotection in cultured human lens epithelial (HLE-B3) cells and normal, secondary cultures of bovine lens epithelial cells, maintained in atmospheric oxygen, was investigated.
Virally transfected human lens epithelial cells (HLE-B3) and normal cultures of bovine lens epithelial cells were exposed to acute hypoxic conditions (about 1% O2) followed by exposure to atmospheric oxygen (about 21% O2). Specific antisera and western blot analysis was used to examine the state of phosphorylation of ERK and GSK-3β, as well as the phosphorylation of a downstream substrate of GSK-3β, glycogen synthase (GS, useful in monitoring GSK-3β activity). The potentiometric dye, 1H-benzimidazolium-5,6-dichloro-2-[3-(5,6-dichloro-1,3-diethyl-1,3-dihydro-2H-benzimidazol-2-ylidene)-1-propenyl]-1,3-diethyl-iodide (JC-1), was used to monitor mitochondrial depolarization upon exposure of inhibitor treatment relative to the control cells (mock inhibition) in atmospheric oxygen. Caspase-3 activation was scrutinized to determine whether mitochondrial depolarization inevitably leads to apoptosis.
Treatment of HLE-B3 cells with SB216763 (12 µM) inactivated GSK-3β activity as verified by the enzyme's inability to phosphorylate its substrate, GS. SB216763-treated cells were not depolarized relative to the control cells as demonstrated with JC-1 fluorescent dye analysis. The HLE-B3 cells treated with UO126, which similarly blocked phosphorylation of GS, were nevertheless prone to mMPT relative to the control cells. Western blot analysis determined that Bcl-2-associated X (BAX) levels were unchanged for SB216763-treated or UO126-treated HLE-B3 cells when compared to their respective control cells. However, unlike the SB216763-treated cells, the UO126-treated cells showed a marked absence of Bcl-2, as well as phosphorylated Bcl-2 relative to the controls. UO126 treatment of bovine lens epithelial cells showed similar results with pBcl-2 levels, while the Bcl-2 content appeared unchanged relative to the control cells. HLE-B3 and normal bovine lens cell cultures showed susceptibility to mMPT associated with the loss of pBcl-2 by UO126 treatment.
MITOCHONDRIAL DEPOLARIZATION MAY OCCUR BY ONE OF TWO KEY OCCURRENCES: interruption of the electrochemical gradient across the inner mitochondrial membrane resulting in mMPT or by disruption of the integrity of the inner or outer mitochondrial membrane. The latter scenario is generally tightly regulated by members of the Bcl-2 family of proteins. Inhibition of GSK-3β activity by SB216763 blocks mMPT by preventing the opening of the mitochondrial permeability transition pore. UO126, likewise, inhibits GSK-3β activity, but unlike SB216763, inhibition of ERK phosphorylation induces the loss of intracellular pBcl-2 levels under conditions where intracellular BAX levels remain constant. These results suggest that the lenticular mitoprotection normally afforded by the inactivation of GSK-3β activity may, however, be bypassed by a loss of pBcl-2, an anti-apoptotic member of the Bcl-2 family. Bcl-2 prevents the translocation of BAX to the mitochondrial outer membrane inhibiting depolarization by disrupting the normal electrochemical gradient leading to mMPT.
线粒体内膜或外膜完整性的丧失会导致线粒体电化学梯度的消散,进而引发线粒体膜通透性转换(mMPT)。本研究强调糖原合酶激酶3β(GSK-3β)在维持线粒体膜电位从而防止线粒体去极化(以下称为线粒体保护)中的作用。使用GSK-3β抑制剂3-(2,4-二氯苯基)-4-(1-甲基-1H-吲哚-3-基)-1H-吡咯-2,5-二酮(SB216763),并将其与细胞外信号调节激酶(ERK)磷酸化抑制剂1,4-二氨基-2,3-二氰基-1,4-双[2-氨基苯硫基]丁二烯(UO126)区分开来,研究了在大气氧条件下培养的人晶状体上皮(HLE-B3)细胞和牛晶状体上皮细胞原代培养物中GSK-3β影响线粒体保护的机制。
将病毒转染的人晶状体上皮细胞(HLE-B3)和牛晶状体上皮细胞正常培养物暴露于急性缺氧条件(约1% O₂),随后再暴露于大气氧(约21% O₂)。使用特异性抗血清和蛋白质免疫印迹分析来检测ERK和GSK-3β的磷酸化状态,以及GSK-3β下游底物糖原合酶(GS,可用于监测GSK-3β活性)的磷酸化情况。使用电位染料1H-苯并咪唑鎓-5,6-二氯-2-[3-(5,6-二氯-1,3-二乙基-1,3-二氢-2H-苯并咪唑-2-亚基)-1-丙烯基]-1,3-二乙基碘化物(JC-1),相对于大气氧条件下的对照细胞(模拟抑制),监测抑制剂处理后线粒体的去极化情况。仔细检查半胱天冬酶-3的激活情况,以确定线粒体去极化是否必然导致细胞凋亡。
用SB216763(12 μM)处理HLE-B3细胞可使GSK-3β活性失活,这通过该酶无法磷酸化其底物GS得到证实。如JC-1荧光染料分析所示,与对照细胞相比,经SB216763处理的细胞未发生去极化。用UO126处理的HLE-B3细胞同样阻断了GS的磷酸化,但相对于对照细胞,它们仍易于发生mMPT。蛋白质免疫印迹分析确定,与各自的对照细胞相比,经SB216763处理或UO126处理的HLE-B3细胞中Bcl-2相关X蛋白(BAX)水平未发生变化。然而,与经SB216763处理的细胞不同,经UO